Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
The drug Wegovy uses an active ingredient called Semaglutide which is part of a growing class of GLP-1 drugs that make people ...
Patients taking semaglutide had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease after three ...
Marketed as Wegovy, Ozempic and Rybelsus, semaglutide injections may benefit obese patients even if they don't lose weight.
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...